4.5 Letter

A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas

Journal

JOURNAL OF NEURO-ONCOLOGY
Volume 133, Issue 2, Pages 443-445

Publisher

SPRINGER
DOI: 10.1007/s11060-017-2447-3

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available